Zala Jevnikar

AstraZeneca, BioPharmaceuticals R&D
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.

The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.

Journal: Respiratory research

Published: September 02, 2025

Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.

Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.

Journal: BMJ open respiratory research

Published: July 04, 2025

First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor.

First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor.

Journal: The Journal of allergy and clinical immunology

Published: June 25, 2025

AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.

AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.

Journal: British journal of clinical pharmacology

Published: April 01, 2025

ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.

ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.

Journal: Respiratory research

Published: March 31, 2025

A sputum 6-gene signature predicts airway inflammation endotypes and exacerbation frequency in chronic obstructive pulmonary disease.

A sputum 6-gene signature predicts airway inflammation endotypes and exacerbation frequency in chronic obstructive pulmonary disease.

Journal: Biomarkers in medicine

Published: February 18, 2022

Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis.

Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis.

Journal: Respiratory research

Published: December 04, 2020

Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.

Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.

Journal: The European respiratory journal

Published: August 28, 2020

T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles.

T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles.

Journal: Respiratory research

Published: January 02, 2020

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: March 26, 2019

IL-17-high asthma with features of a psoriasis immunophenotype.

IL-17-high asthma with features of a psoriasis immunophenotype.

Journal: The Journal of allergy and clinical immunology

Published: August 17, 2018

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Journal: The Journal of allergy and clinical immunology

Published: October 11, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026